Interesting. Is there a reason why it has fallen so much since you joined?
•
11
•
1Mes
@Multibagger Interesting question. For me, this is more of a consolidation after the IPO hype. Operationally, CapsoVision is growing at a double-digit rate, has fresh capital (USD 23 million) thanks to the IPO and is working on products with great market potential. The decisive catalyst remains the approval of the Colon capsule. 510(k) decision expected in Q1 2026. Until then, investors are likely to be somewhat cautious.
•
11
•